Laser modulated transmembrane convection: Implementation in cancer chemotherapy

J Control Release. 2010 Dec 1;148(2):131-4. doi: 10.1016/j.jconrel.2010.10.010. Epub 2010 Oct 8.

Abstract

Transmembrane diffusion imposes fundamental limits to the uptake of cytostatic drugs executing their function intracellularly. Here, we report that transmembrane convection-a mechanism exploiting the effect of moderately intense 670nm laser light on the density and viscosity of nanoscopic interfacial water layers (IWL) in the cell-forces cancer cells to uptake high doses of cytostatic drugs in a short time. Transmembrane convection is a viable alternative to established uptake forms (i.e., it works complementary to diffusive processes) and breaks the limits imposed by diffusion. We demonstrate the potency of the method in human cervical cancer cells, HeLa, using the anticancer compounds doxorubicin (DOX), methotrexate (MTX) and epigallocatechin gallate (EGCG). The method is applicable to virtually the entire chemotherapeutic arsenal and is expected to help overcome multidrug resistance in cancer cells.

MeSH terms

  • Antineoplastic Agents / metabolism*
  • Biological Transport
  • Catechin / analogs & derivatives
  • Catechin / metabolism
  • Cell Count
  • Cell Membrane / metabolism
  • Cell Membrane / radiation effects*
  • Cell Membrane Permeability / radiation effects*
  • Diffusion
  • Doxorubicin / metabolism
  • Drug Resistance, Neoplasm
  • Female
  • HeLa Cells
  • Humans
  • Lasers*
  • Methotrexate / metabolism
  • Models, Biological
  • Time Factors
  • Uterine Cervical Neoplasms / metabolism*
  • Viscosity

Substances

  • Antineoplastic Agents
  • Doxorubicin
  • Catechin
  • epigallocatechin gallate
  • Methotrexate